Geron Corporation (GERN)
NASDAQ: GERN · Real-Time Price · USD
1.310
+0.040 (3.15%)
At close: Dec 5, 2025, 4:00 PM EST
1.300
-0.010 (-0.76%)
After-hours: Dec 5, 2025, 7:24 PM EST
Geron Market Cap
Geron has a market cap or net worth of $836.25 million as of December 5, 2025. Its market cap has decreased by -63.40% in one year.
Market Cap
836.25M
Enterprise Value
538.57M
1-Year Change
-63.40%
Ranking
Category
Stock Price
$1.31
Market Cap Chart
Since December 1, 1998, Geron's market cap has increased from $159.40M to $836.25M, an increase of 424.62%. That is a compound annual growth rate of 6.32%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 4, 2025 | 810.70M | -62.12% |
| Dec 31, 2024 | 2.14B | 86.74% |
| Dec 29, 2023 | 1.15B | 24.20% |
| Dec 30, 2022 | 922.60M | 134.88% |
| Dec 31, 2021 | 392.80M | -20.44% |
| Dec 31, 2020 | 493.70M | 81.71% |
| Dec 31, 2019 | 271.70M | 45.84% |
| Dec 31, 2018 | 186.30M | -35.00% |
| Dec 29, 2017 | 286.60M | -12.99% |
| Dec 30, 2016 | 329.40M | -56.99% |
| Dec 31, 2015 | 765.80M | 49.89% |
| Dec 31, 2014 | 510.90M | -16.42% |
| Dec 31, 2013 | 611.30M | 231.51% |
| Dec 31, 2012 | 184.40M | -5.24% |
| Dec 30, 2011 | 194.60M | -63.43% |
| Dec 31, 2010 | 532.20M | 4.66% |
| Dec 31, 2009 | 508.50M | 37.54% |
| Dec 31, 2008 | 369.70M | -13.62% |
| Dec 31, 2007 | 428.00M | -26.52% |
| Dec 29, 2006 | 582.50M | 4.37% |
| Dec 30, 2005 | 558.10M | 53.45% |
| Dec 31, 2004 | 363.70M | -6.72% |
| Dec 31, 2003 | 389.90M | 337.60% |
| Dec 31, 2002 | 89.10M | -53.52% |
| Dec 31, 2001 | 191.70M | -42.86% |
View and export this data all the way back to 1998.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 925.43B |
| Johnson & Johnson | 494.70B |
| AbbVie | 406.92B |
| UnitedHealth Group | 307.72B |
| AstraZeneca | 283.29B |
| Novartis AG | 257.47B |
| Merck & Co. | 253.84B |
| Thermo Fisher Scientific | 218.08B |